Palvella Therapeutics, Inc. (PVLA)
138.96
+7.62
(+5.80%)
USD |
NASDAQ |
Oct 09, 16:00
138.96
0.00 (0.00%)
After-Hours: 16:52
Palvella Therapeutics Price : 138.96 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 129.90 | 131.95 | 124.49 | 131.34 | 209331.0 |
| Oct 07, 2026 | 125.97 | 131.34 | 125.00 | 130.59 | 151992.0 |
| Oct 06, 2026 | 133.75 | 133.85 | 124.97 | 128.00 | 309986.0 |
| Oct 05, 2026 | 132.50 | 133.26 | 129.51 | 132.16 | 142876.0 |
| Oct 02, 2026 | 135.15 | 137.04 | 127.26 | 132.47 | 348127.0 |
| Oct 01, 2026 | 135.57 | 139.23 | 131.65 | 132.73 | 343370.0 |
| Sep 30, 2026 | 141.14 | 142.96 | 137.30 | 137.93 | 262310.0 |
| Sep 29, 2026 | 140.20 | 141.54 | 136.18 | 139.00 | 215009.0 |
| Sep 28, 2026 | 138.13 | 143.55 | 137.42 | 139.83 | 188616.0 |
| Sep 25, 2026 | 147.02 | 147.44 | 137.86 | 138.16 | 193342.0 |
| Sep 24, 2026 | 148.05 | 149.11 | 143.08 | 146.07 | 185057.0 |
| Sep 23, 2026 | 157.62 | 157.62 | 147.43 | 149.56 | 180604.0 |
| Sep 22, 2026 | 155.08 | 160.84 | 153.64 | 158.13 | 276629.0 |
| Sep 21, 2026 | 152.40 | 155.11 | 151.31 | 153.41 | 123592.0 |
| Sep 18, 2026 | 154.72 | 154.72 | 149.20 | 150.56 | 646463.0 |
| Sep 17, 2026 | 154.78 | 156.78 | 151.55 | 154.32 | 157921.0 |
| Sep 16, 2026 | 152.54 | 155.18 | 150.76 | 151.43 | 201973.0 |
| Sep 15, 2026 | 152.72 | 155.63 | 148.14 | 151.22 | 215632.0 |
| Sep 14, 2026 | 150.14 | 153.40 | 150.14 | 151.69 | 223049.0 |
| Sep 11, 2026 | 152.75 | 154.30 | 149.98 | 150.13 | 163366.0 |
| Sep 10, 2026 | 148.43 | 151.36 | 147.10 | 150.39 | 266083.0 |
| Sep 09, 2026 | 147.26 | 155.00 | 145.91 | 151.34 | 149392.0 |
| Sep 08, 2026 | 153.42 | 157.93 | 151.58 | 152.28 | 165031.0 |
| Sep 04, 2026 | 152.95 | 157.45 | 152.95 | 157.24 | 162268.0 |
| Sep 03, 2026 | 152.95 | 155.92 | 150.76 | 155.47 | 249669.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.655 |
| Amgen, Inc. | 414.79 |
| BioCryst Pharmaceuticals, Inc. | 8.56 |
| Imunon, Inc. | 1.08 |
| Curis, Inc. | 0.6668 |
Price Related Metrics
| Price to Book Value | 9.224 |
| Earnings Yield | -3.48% |
| Market Cap | 2.000B |